The 5th iPSC Drug Development and Manufacturing Summit returns to Boston with renewed clinical momentum, introducing two new tracks on Preclinical Development and Process Development & CMC to tackle early-stage and scale-up challenges. With essential workshops on cell line selection and industry-wide QC standards, this is the key forum to connect with the iPSC community and drive your program toward clinical success.

Date: September 30-October 2, 2025
Location: Boston, MA

JOIN US!

Join us as we unpack real-world insights and forward-thinking strategies in iPSC drug development and manufacturing. Whether you’re navigating early-stage challenges or scaling for clinical success, our session is designed to offer practical solutions. Meet our team, learn from our experiences, and discover how we’re shaping the next era of cell therapy.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS

Speaker: Frederic Cedrone
Day/time: Day 1, October 1st at 5pm – Main Stage

Title: Leveraging Partnerships to Accelerate the Journey from an iPSC Line to a Patient Cure

The critical early-decision steps and technologies used in many ways will shape the timelines and both the clinical and commercial viability of iPSC-based therapies. We will highlight key steps in the iPSC drug development chain where leveraging partnerships can streamline and fast-track breakthrough innovations into patient-ready cures.
The talk will focus on:
1. The challenges with sourcing fit for purpose iPSC lines from earliest steps and the substantial gains with accessing high-quality GMP-compliant lines, with required regulatory documentation and consents, from day one.
2. How to fast-track drug development and secure value chain by onboarding gene-editing methodologies, differentiation and expansion protocols developed for scalability and GMP-compatibility, and patented.
3. The importance of teaming from early days with an expert manufacturing partner, who has a sharp understanding of the partner program, strategic plans, and environment, and can take programs from very initial steps to late and commercial stage, delivering on critical milestones.

ABOUT CATALENT

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. www.catalent.com.

 

 

More products. Better treatments. Reliably supplied.™